| Anne Tyson, Lmsw Llc | |
|
1810 Ruddiman Dr Ste D North Muskegon MI 49445-3172 | |
| (616) 843-0623 | |
| Not Available |
| Full Name | Anne Tyson, Lmsw Llc |
|---|---|
| Speciality | Social Worker |
| Location | 1810 Ruddiman Dr Ste D, North Muskegon, Michigan |
| Authorized Official Name and Position | Anne Tyson (OWNER/CLINICIAN) |
| Authorized Official Contact | 6168430623 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Anne Tyson, Lmsw Llc 1154 Cadillac Dr Muskegon MI 49445-1917 Ph: (616) 843-0623 | Anne Tyson, Lmsw Llc 1810 Ruddiman Dr Ste D North Muskegon MI 49445-3172 Ph: (616) 843-0623 |
| NPI Number | 1144703182 |
|---|---|
| Provider Enumeration Date | 09/14/2018 |
| Last Update Date | 12/21/2023 |
| Certification Date | 12/21/2023 |
| Medicare PECOS PAC ID | 0941544845 |
|---|---|
| Medicare Enrollment ID | O20181204001353 |
News Archive
A method for finding genes that spur tumor growth takes advantage of machine learning algorithms to sift through reams of molecular data collected from studies of cancer cell lines, mouse models and human patients.
INVO Bioscience, Inc., a medical device company focused on treatment options for patients diagnosed with infertility, announced that on September 29, 2009 the birth of the first baby conceived by the INVO procedure and INVOcell device. The mother is a 40 year old Pakistan woman who had suffered from infertility for 16 years.
MabCure, Inc., a biotechnology company using its proprietary technology to create highly specific monoclonal antibodies (MAbs) for the early detection of cancer, today announced that it has recently completed a private placement in the aggregate amount of $1 million. The amount is comprised of a $500,000 cash investment and the conversion of a $500,000 bridge loan that was made in September 2009, into equity securities.
In spite of the difference between the cell functions responsible for giving rise to a tumor and for the metastasis of this same tumor, studies at IRB Barcelona using the fly Drosophila melanogaster reveal that some genes can drive both phenomena.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144703182 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
| Provider Name | Anne Tyson |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1447472915 PECOS PAC ID: 0648280495 Enrollment ID: I20060425000312 |
News Archive
A method for finding genes that spur tumor growth takes advantage of machine learning algorithms to sift through reams of molecular data collected from studies of cancer cell lines, mouse models and human patients.
INVO Bioscience, Inc., a medical device company focused on treatment options for patients diagnosed with infertility, announced that on September 29, 2009 the birth of the first baby conceived by the INVO procedure and INVOcell device. The mother is a 40 year old Pakistan woman who had suffered from infertility for 16 years.
MabCure, Inc., a biotechnology company using its proprietary technology to create highly specific monoclonal antibodies (MAbs) for the early detection of cancer, today announced that it has recently completed a private placement in the aggregate amount of $1 million. The amount is comprised of a $500,000 cash investment and the conversion of a $500,000 bridge loan that was made in September 2009, into equity securities.
In spite of the difference between the cell functions responsible for giving rise to a tumor and for the metastasis of this same tumor, studies at IRB Barcelona using the fly Drosophila melanogaster reveal that some genes can drive both phenomena.
› Verified 9 days ago
News Archive
A method for finding genes that spur tumor growth takes advantage of machine learning algorithms to sift through reams of molecular data collected from studies of cancer cell lines, mouse models and human patients.
INVO Bioscience, Inc., a medical device company focused on treatment options for patients diagnosed with infertility, announced that on September 29, 2009 the birth of the first baby conceived by the INVO procedure and INVOcell device. The mother is a 40 year old Pakistan woman who had suffered from infertility for 16 years.
MabCure, Inc., a biotechnology company using its proprietary technology to create highly specific monoclonal antibodies (MAbs) for the early detection of cancer, today announced that it has recently completed a private placement in the aggregate amount of $1 million. The amount is comprised of a $500,000 cash investment and the conversion of a $500,000 bridge loan that was made in September 2009, into equity securities.
In spite of the difference between the cell functions responsible for giving rise to a tumor and for the metastasis of this same tumor, studies at IRB Barcelona using the fly Drosophila melanogaster reveal that some genes can drive both phenomena.
› Verified 9 days ago
True You Coaching And Counseling Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 318 Center St Ste C, North Muskegon, MI 49445 Phone: 231-206-8079 |